Navigation Links
A new Vaccine for Pneumonia

Researchers show a new type of vaccine can reduce the incidence of pneumonia in children with and without human immunodeficiency virus (HIV). //

Acute respiratory infections are a major cause of death in children under age 5. Additionally, pneumonia is becoming increasingly resistant to antibiotics. Doctors from around the world are in search of new methods to treat the illness. Researchers, conducted a study with nearly 40,000 children in South Africa. At 6 weeks, 10 weeks and 14 weeks of age, half of the children received the 9-valent pneumococcal polysaccharide vaccine. All of the children received the flu vaccine.

The researchers found the pneumonia vaccine decreased the rate of the particular strain of pneumonia in the vaccine, by 72 percent. It also reduced the rate of confirmed cases by 17 percent. In an accompanying editorial, the authors write, “The decrease in these two outcomes were remarkably similar in both U.S. children and South African children. However, in South Africa about one third of the cases of invasive disease caused by serotypes included in the vaccine were associated with meningitis, a much higher proportion than in the United States.”

This vaccine, according to the study investigators, may be useful in countries where HIV infection is a significant cause of pneumonia. It also may reduce the risk of antibiotic resistance. However researchers noted an increase in asthma in those who received the vaccine, but that reason is not yet understood.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: new Vaccine for Pneumonia

(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...ia Medical School presented their study that shows...tic neuropathy, or nerve damage.Topiramate (Topama...t research shows it can also promote significant w...2 diabetes, the drug showed evidence of improving ...
...p the hearts of children with diabetes. Researcher...indings over the weekend at the American Diabetes ...ding to the American Diabetes Association, people ...likely to have heart disease as compared to those ...
...s to numerous health concerns. But a new study fin...ink weight to athletic performance and appearance ...s also fail to see the importance of a healthy wei...n children more in terms of appearance and self-es...
... can have a serious impact on their health and qua... Educators (AADE) says about a third of the estima...sis, the most common type of nail fungus. Because ...ced ability to fight infection, people with diabet...
Other Medicine News:
(Date:10/9/2008)... World Sight Day 2008 focuses on the need to ...ct. 9 /- Of the 45 million people wor...and three-quarters of them could,have avoided thei...,treated., To view the Multimedia News Release, g..., Alcon, the world,s leader in eye care products ...
(Date:10/9/2008)... Top Line Clinical Results Expected in Novemb...Call/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announce...osing,for the third of its three pivotal trials to...on of 12-hour extended-release (ER) ibuprofen for,...ects to report top-line,results from this pivotal ...
(Date:10/9/2008)... STOCKHOLM, October 9 /PRNewswire-FirstCall/ ...fluential medical journal, the New England Journal...s from the company,s study,of the Diamyd(R) diabet...ww.newscom.com/cgi-bin/prnh/20080314/297194 ), T...ite,( http://www.nejm.org ) and will be in print o...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmeti.../- MatTek Corp. today announced,that ...lti-laboratory,"catch-up" validation study on MatT.... The test results demonstrated the required sensi...as a validated alternative to animal,testing for d...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 1Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 2Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 3Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 4Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 5Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 6Muscle mass 3A Scientists identify novel mode of transcriptional regulation during myogenesis 92 1A new radiation therapy treatment developed for head and neck cancer patients 87 1A new radiation therapy treatment developed for head and neck cancer patients 87 2Scientists retrace evolution with first atomic structure of an ancient protein 82 1Scientists retrace evolution with first atomic structure of an ancient protein 82 2Scientists retrace evolution with first atomic structure of an ancient protein 82 3
...d, April 27, 2007 –,Merck Serono S.A. (virt-....A. (SWX: NWRN) announced today that Professor,Fab...f the first,Phase III trial of safinamide as an ad...rly Parkinson’s disease (PD),patients at the...,to be held in Boston from 28 April to 5 May 2007....
...il 30. 2007-- Scientific evidence,increasingly lin...ized particles -- so small that some scientists qu... play a viable role in,causing disease. , ,A new M...ce of,nanoparticles near plaque-filled arteries in...les potentially represent a,previously unrecognize...
Other Medicine Technology:Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 2Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 3Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 4Evidence of Nanoparticles Found in Plaque-Filled Arteries 2
...the rapid, detection of platelet dysfunction. It i... that uniquely simulates the in vivo function of p...s platelet function under high shear conditions si...lood vessel. Testing is performed using a small wh...
...rming erythrocyte sedimentation rate (ESR) tests u...es-matic System DIESSE brings to the clinical diag... which addresses and resolves every technical limi...e.,By means of a fully automated analyzer and a es...
...n rate analysers, which are especially user-friend...stablished advantages of the existing analysers wi...rantee time-saving standardised analysis of the er...s an essential aspect of daily recurrent routine a...
Blood sedimentation rate analysis
Medicine Products: